Gemtuzumab ozogamicin as first‐line treatment in patients aged 70 years or older with acute myeloid leukemia
W McHayleh, K Foon, R Redner, R Sehgal, A Raptis… - Cancer, 2010 - Wiley Online Library
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …
[PDF][PDF] Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia
W McHayleh, K Foon, R Redner, R Sehgal, A Raptis - Cancer, 2010 - academia.edu
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …
Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia.
W McHayleh, K Foon, R Redner, R Sehgal, A Raptis… - Cancer, 2010 - europepmc.org
Background Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …
[引用][C] Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia
W MCHAYLEH, K FOON, R REDNER, R SEHGAL… - Cancer, 2010 - pascal-francis.inist.fr
Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With
Acute Myeloid Leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Acute Myeloid Leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia
W McHayleh, K Foon, R Redner, R Sehgal… - Cancer, 2010 - pubmed.ncbi.nlm.nih.gov
Background Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …
Gemtuzumab ozogamicin as first‐line treatment in patients aged 70 years or older with acute myeloid leukemia
W McHayleh, K Foon, R Redner, R Sehgal, A Raptis… - Cancer, 2010 - infona.pl
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …
[PDF][PDF] Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia
W McHayleh, K Foon, R Redner, R Sehgal, A Raptis - Cancer, 2010 - academia.edu
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to
withstand the rigors of intensive induction chemotherapy and its attendant complications …
withstand the rigors of intensive induction chemotherapy and its attendant complications …